    
{"id":12479,"date":"2022-03-02T17:36:14","date_gmt":"2022-03-02T16:36:14","guid":{"rendered":"https:\/\/www.abenex.com\/prevost-laboratory-concept-optimises-its-financing-structure\/"},"modified":"2024-02-27T11:26:52","modified_gmt":"2024-02-27T10:26:52","slug":"prevost-laboratory-concept-optimises-its-financing-structure","status":"publish","type":"post","link":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/","title":{"rendered":"Prevost Laboratory Concept optimises its financing structure"},"content":{"rendered":"\r\n<p>Less than two years after Abenex Croissance became its majority shareholder, Prevost Laboratory Concept, a company specialised in the conception and the manufacturing of cosmetics and dietary supplements, has completed a refinancing.\u00a0<\/p>\r\n\r\n\r\n\r\n<p>\u201cThis operation intervenes in a context of the business\u2019 outperformance, generating financial results above initial forecasts. The company is led by Marc-Henry Lussigny and his team and has become a leading player in the cosmetics market\u201d adds Paul Bertrand, Partner at Abenex.<\/p>\r\n\r\n\r\n\r\n<p>The company has recorded a growth rate close to 25% over 2021, while production capacity allows it to meet its development plan\u2019s requirements going forward.<\/p>\r\n\r\n\r\n\r\n<p>Thanks to its refinancing, the company maintains its ability to pursue potential future external growth acquisitions.<\/p>\r\n\r\n\r\n\r\n<p>This operation was carried out with the support of \u201cArkea Banque Entreprises et Institutionnels\u201d &#8211; which had already provided financing for the 2020 transaction &#8211; and the Cr\u00e9dit Agricole Ille-et-Vilaine.<\/p>\r\n\r\n\r\n\r\n<p>Arkea Capital remains a shareholder alongside Abenex and the Management.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Less than two years after Abenex Croissance became its majority shareholder, Prevost Laboratory Concept, a company specialised in the conception and the manufacturing of cosmetics and dietary supplements, has completed a refinancing.\u00a0 \u201cThis operation intervenes in a context of the business\u2019 outperformance, generating financial results above initial forecasts. The company is led by Marc-Henry Lussigny [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":12711,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[173,178],"tags":[],"class_list":["post-12479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-abenex-nl","category-participatie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prevost Laboratory Concept optimises its financing structure | Abenex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prevost Laboratory Concept optimises its financing structure | Abenex\" \/>\n<meta property=\"og:description\" content=\"Less than two years after Abenex Croissance became its majority shareholder, Prevost Laboratory Concept, a company specialised in the conception and the manufacturing of cosmetics and dietary supplements, has completed a refinancing.\u00a0 \u201cThis operation intervenes in a context of the business\u2019 outperformance, generating financial results above initial forecasts. The company is led by Marc-Henry Lussigny [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\" \/>\n<meta property=\"og:site_name\" content=\"Abenex\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-02T16:36:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-27T10:26:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/06\/logo-prevost-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"348\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alec\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alec\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\"},\"author\":{\"name\":\"Alec\",\"@id\":\"https:\/\/www.abenex.com\/#\/schema\/person\/1c0ae1a065aca059d6abd16affb29251\"},\"headline\":\"Prevost Laboratory Concept optimises its financing structure\",\"datePublished\":\"2022-03-02T16:36:14+00:00\",\"dateModified\":\"2024-02-27T10:26:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\"},\"wordCount\":161,\"publisher\":{\"@id\":\"https:\/\/www.abenex.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png\",\"articleSection\":[\"Abenex\",\"Participatie\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\",\"url\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\",\"name\":\"Prevost Laboratory Concept optimises its financing structure | Abenex\",\"isPartOf\":{\"@id\":\"https:\/\/www.abenex.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png\",\"datePublished\":\"2022-03-02T16:36:14+00:00\",\"dateModified\":\"2024-02-27T10:26:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage\",\"url\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png\",\"contentUrl\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png\",\"width\":389,\"height\":263,\"caption\":\"Prevost Laboratory\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.abenex.com\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prevost Laboratory Concept optimises its financing structure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.abenex.com\/#website\",\"url\":\"https:\/\/www.abenex.com\/\",\"name\":\"Abenex - Investing with purpose\",\"description\":\"Investing with purpose\",\"publisher\":{\"@id\":\"https:\/\/www.abenex.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.abenex.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.abenex.com\/#organization\",\"name\":\"Abenex - Investing with purpose\",\"url\":\"https:\/\/www.abenex.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.abenex.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/05\/FULL-LOGO-NOIR-BLEU-1.svg\",\"contentUrl\":\"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/05\/FULL-LOGO-NOIR-BLEU-1.svg\",\"width\":166,\"height\":34,\"caption\":\"Abenex - Investing with purpose\"},\"image\":{\"@id\":\"https:\/\/www.abenex.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.abenex.com\/#\/schema\/person\/1c0ae1a065aca059d6abd16affb29251\",\"name\":\"Alec\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.abenex.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0c04920c00470302b1a500200942400268abc1c78754ad098dc67d526944251c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0c04920c00470302b1a500200942400268abc1c78754ad098dc67d526944251c?s=96&d=mm&r=g\",\"caption\":\"Alec\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prevost Laboratory Concept optimises its financing structure | Abenex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/","og_locale":"nl_NL","og_type":"article","og_title":"Prevost Laboratory Concept optimises its financing structure | Abenex","og_description":"Less than two years after Abenex Croissance became its majority shareholder, Prevost Laboratory Concept, a company specialised in the conception and the manufacturing of cosmetics and dietary supplements, has completed a refinancing.\u00a0 \u201cThis operation intervenes in a context of the business\u2019 outperformance, generating financial results above initial forecasts. The company is led by Marc-Henry Lussigny [&hellip;]","og_url":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/","og_site_name":"Abenex","article_published_time":"2022-03-02T16:36:14+00:00","article_modified_time":"2024-02-27T10:26:52+00:00","og_image":[{"width":348,"height":200,"url":"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/06\/logo-prevost-1.jpg","type":"image\/jpeg"}],"author":"Alec","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Alec","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#article","isPartOf":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/"},"author":{"name":"Alec","@id":"https:\/\/www.abenex.com\/#\/schema\/person\/1c0ae1a065aca059d6abd16affb29251"},"headline":"Prevost Laboratory Concept optimises its financing structure","datePublished":"2022-03-02T16:36:14+00:00","dateModified":"2024-02-27T10:26:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/"},"wordCount":161,"publisher":{"@id":"https:\/\/www.abenex.com\/#organization"},"image":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage"},"thumbnailUrl":"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png","articleSection":["Abenex","Participatie"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/","url":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/","name":"Prevost Laboratory Concept optimises its financing structure | Abenex","isPartOf":{"@id":"https:\/\/www.abenex.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage"},"image":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage"},"thumbnailUrl":"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png","datePublished":"2022-03-02T16:36:14+00:00","dateModified":"2024-02-27T10:26:52+00:00","breadcrumb":{"@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#primaryimage","url":"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png","contentUrl":"https:\/\/www.abenex.com\/wp-content\/uploads\/2017\/04\/Prevost-Laboratory.png","width":389,"height":263,"caption":"Prevost Laboratory"},{"@type":"BreadcrumbList","@id":"https:\/\/www.abenex.com\/nl\/prevost-laboratory-concept-optimises-its-financing-structure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.abenex.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Prevost Laboratory Concept optimises its financing structure"}]},{"@type":"WebSite","@id":"https:\/\/www.abenex.com\/#website","url":"https:\/\/www.abenex.com\/","name":"Abenex - Investing with purpose","description":"Investing with purpose","publisher":{"@id":"https:\/\/www.abenex.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.abenex.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.abenex.com\/#organization","name":"Abenex - Investing with purpose","url":"https:\/\/www.abenex.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.abenex.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/05\/FULL-LOGO-NOIR-BLEU-1.svg","contentUrl":"https:\/\/www.abenex.com\/wp-content\/uploads\/2023\/05\/FULL-LOGO-NOIR-BLEU-1.svg","width":166,"height":34,"caption":"Abenex - Investing with purpose"},"image":{"@id":"https:\/\/www.abenex.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.abenex.com\/#\/schema\/person\/1c0ae1a065aca059d6abd16affb29251","name":"Alec","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.abenex.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0c04920c00470302b1a500200942400268abc1c78754ad098dc67d526944251c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0c04920c00470302b1a500200942400268abc1c78754ad098dc67d526944251c?s=96&d=mm&r=g","caption":"Alec"}}]}},"_links":{"self":[{"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/posts\/12479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/comments?post=12479"}],"version-history":[{"count":1,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/posts\/12479\/revisions"}],"predecessor-version":[{"id":12481,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/posts\/12479\/revisions\/12481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/media\/12711"}],"wp:attachment":[{"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/media?parent=12479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/categories?post=12479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abenex.com\/nl\/wp-json\/wp\/v2\/tags?post=12479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}